Consensus Cencora, Inc.

Stocks

COR

US03073E1055

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:00:03 2026-10-13 EDT			5-day change	1st Jan Change
330.11 ^USD	+1.55%		+4.34%	-2.26%

10-12	Baird Adjusts Price Target on Cencora to $373 From $370	MT
10-07	Leerink Partners Adjusts Price Target on Cencora to $388 From $380	MT

Evolution of the Average Target: Cencora, Inc.

Evolution of the Target Price: Cencora, Inc.

Changes in Analyst Recommendations: Cencora, Inc.

d1ff139f305ec4aedc990b.dV-5HvVyixuPiV1Frxucw5fwQyYBUj3fvNJk4rn3EB4.Ey7Ve7sn-23J5BAm7nKpotOeCxV4ZQ2riYsoj8CZKUwNJ4lPvhzPK8bGBA~518143a7cf49063c37c259f0888b9003

Analysts' recommendations: Cencora, Inc.

10-12	Baird Adjusts Price Target on Cencora to $373 From $370	MT
10-07	Leerink Partners Adjusts Price Target on Cencora to $388 From $380	MT
08-19	RBC Initiates Cencora at Sector Perform With $330 Price Target	MT
08-11	Wells Fargo Adjusts Price Target on Cencora to $395 From $331, Keeps Overweight Rating	MT
08-07	JPMorgan Adjusts Price Target on Cencora to $390 From $382	MT
08-06	Citigroup Adjusts Price Target on Cencora to $370 From $355	MT
08-06	Leerink Partners Adjusts Price Target on Cencora to $380 From $368	MT
08-06	Evercore ISI Adjusts Price Target on Cencora to $350 From $330	MT
08-06	Baird Adjusts Price Target on Cencora to $370 From $340	MT
08-06	UBS Adjusts Price Target on Cencora to $430 From $412, Maintains Buy Rating	MT
07-22	Baird Adjusts Price Target on Cencora to $340 From $337, Maintains Outperform Rating	MT
07-21	BofA Securities Adjusts Cencora Price Target to $310 From $285	MT
07-07	Evercore ISI Adjusts Price Target on Cencora to $330 From $300	MT
06-24	Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating	MT
06-24	BofA Adjusts Price Target on Cencora to $285 From $280	MT
06-10	Barclays Cuts Cencora Price Target to $350 From $425, Maintains Overweight Rating	MT
05-21	Baird Adjusts Price Target on Cencora to $337 From $339, Maintains Outperform Rating	MT
05-11	Wells Fargo Adjusts Price Target on Cencora to $331 From $429	MT
05-08	McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says	MT
05-08	Morgan Stanley Lowers Price Target on Cencora to $342 From $400, Keeps Overweight Rating	MT
05-07	UBS Adjusts Price Target on Cencora to $412 From $410, Maintains Buy Rating	MT
04-28	William Blair Initiates Cencora at Market Perform	MT
04-08	Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating	MT
03-19	Baird Adjusts Price Target on Cencora to $420 From $415, Maintains Outperform Rating	MT
03-02	Leerink Partners Adjusts Price Target on Cencora to $447 From $410, Maintains Outperform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CENCORA, INC.					+13.8%
	ABBOTT LABORATORIES					+18.56%
	MEDTRONIC PLC					+13.61%
	STRYKER CORPORATION					+28.31%
	ESSILORLUXOTTICA					+52.61%
	HOYA CORPORATION					+20.53%
	BECTON, DICKINSON AND COMPANY					+2.75%
	IDEXX LABORATORIES, INC.					+33.86%
	MEDLINE INC.					+24.23%
	DEXCOM, INC.					+12%
	Average					+22.03%
	Weighted average by Cap.					+22.07%